Nureca Adjusts Evaluation Score Amid Mixed Technical Indicators and Growth Challenges
Nureca, a microcap healthcare services company, has recently adjusted its evaluation score, reflecting a shift in technical trends. While the company shows mixed technical indicators, it faces challenges with long-term growth due to declining net sales and operating profit over the past five years, alongside a negative EBITDA.
Nureca, a microcap company in the healthcare services sector, has recently undergone an adjustment in its evaluation score. This revision reflects a shift in technical trends, moving from a mildly bullish stance to a more neutral position. The company's technical indicators present a mixed picture. The MACD shows bullish momentum on a weekly basis, while the monthly outlook leans mildly bearish. The Relative Strength Index (RSI) indicates no significant signals for both weekly and monthly periods. Additionally, Bollinger Bands suggest a bullish trend weekly, contrasted by a bearish stance monthly. Moving averages indicate a mildly bearish trend on a daily basis, while the KST and On-Balance Volume (OBV) metrics show a bullish trend on a weekly basis but a mildly bullish outlook monthly.
Despite a positive financial performance in the most recent quarter, Nureca faces challenges with long-term growth, as evidenced by a decline in net sales and operating profit over the past five years. The company has also reported a negative EBITDA, indicating potential risks associated with its valuation.
Institutional investors have shown increased participation, raising their stake by 0.71% in the last quarter, which may reflect a deeper analysis of the company's fundamentals.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
